Europe Non-invasive Aesthetic Treatment Market Size, Share & Industry Trends Analysis Report By End-Use (MedSpa, Hospital/Surgery Center, Traditional Spa, and HCP Owned Clinic), By Procedure, By Country and Growth Forecast, 2021-2027

The Europe Non-invasive Aesthetic Treatment Market is expected to witness market growth of 14.2% CAGR during the forecast period (2021-2027).

Some of the important factors must be considered while going for a non-invasive treatment. It is required to make sure that the patient is provided with the top up treatments. The body will use the injected substances for a long time (between 6-12 months depending on the individual’s metabolism) due to which having the top up treatment is more preferred in order to ensure safety.

Non-invasive treatments such as laser procedures, radio frequency treatments, and others, is expected to result in  minimal or no pain & discomfort to individuals. However, some treatments may have a bit of side effects but they usually disappear within a couple of days. Also, the non-invasive procedures do not include scalpels or incisions. This makes it clear, there is no requirement of stiches and thus, no scars is expected to occur. 

The demand for cosmetic procedures is increasing significantly in the Europe region. This is because of the efficient healthcare facilities in the region. Rising consciousness regarding the overall fitness & appearance has increased the adoption of non-invasive aesthetic treatments. The most commonly practiced cosmetic treatments in the United Kingdom are breast augmentation, breast reduction and the laser treatment.

Furthermore, the government of the United Kingdom has not defined any regulations over non-surgical laser treatment practices. This means that there are no restrictions that laser tattoo removal or hair removal treatment practices can be done by only a particular group and which equipment is to be used for such treatments. This encourages the providers to open MedSpa & private clinics for these treatments.

The Germany market dominated the Europe Non-invasive Aesthetic Treatment Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $8.5 billion by 2027. The UK market is poised to grow at a CAGR of 13.4% during (2021 - 2027). Additionally, The France market is expected to display a CAGR of 15% during (2021 - 2027).

Based on End-Use, the market is segmented into MedSpa, Hospital/Surgery Center, Traditional Spa, and HCP Owned Clinic. Based on Procedure, the market is segmented into Injectables, Skin Rejuvenation, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Alma Lasers Ltd., Allergan PLC, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Johnson & Johnson, Candela Medical Corporation, Bausch Health Companies, Inc., Cutera, Inc., Lumenis Ltd., and Hologic, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End-use

• MedSpa
• Hospital/Surgery Center
• Traditional Spa
• HCP Owned Clinic

By Procedure

• Injectables
• Skin Rejuvenation
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Alma Lasers Ltd.
• Allergan PLC
• Galderma S.A.
• Merz Pharma GmbH & Co. KGaA
• Johnson & Johnson
• Candela Medical Corporation
• Bausch Health Companies, Inc.
• Cutera, Inc.
• Lumenis Ltd.
• Hologic, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free